Mylan Inc. (NASDAQ: MYL) is a global generic and specialty pharmaceuticals company headquartered in Canonsburg, Pennsylvania. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs,[6] and the generics business of Germany-based Merck KGaA.[7] Through these acquisitions, Mylan has grown from the third largest generic and pharmaceuticals company in the U.S. to the third largest generic and specialty pharmaceuticals company in the world.[8] Mylan now has approximately 18,000 employees,[2] more than 1,000 separate products,[2] and serves customers in more than 150 countries and territories.[2] Mylan has a global manufacturing of more than 45 billion doses.[2] read more